IBS-diarrhea
Showing 1 - 25 of 1,805
Irritable Bowel Syndrome-bile Acid Diarrhea Trial in Rochester (BB01)
Not yet recruiting
- Irritable Bowel Syndrome-bile Acid Diarrhea
- BB01
-
Rochester, MinnesotaMayo Clinic Minnesota
Aug 31, 2023
Diarrhea-Predominant Irritable Bowel Syndrome Trial (Changyanning tablet, Changyanning tablet )
Not yet recruiting
- Diarrhea-Predominant Irritable Bowel Syndrome
- Changyanning tablet
- Changyanning tablet placebo
- (no location specified)
Jan 13, 2023
Irritable Bowel Syndrome With Diarrhea Trial (CIN-103, Placebo)
Not yet recruiting
- Irritable Bowel Syndrome With Diarrhea
- CIN-103
- Placebo
- (no location specified)
Nov 22, 2023
IBS - Irritable Bowel Syndrome, Diarrhea Trial in Shanghai, Chengdu (QiMeiYan Probiotics, Placebo product)
Not yet recruiting
- IBS - Irritable Bowel Syndrome
- Diarrhea
- QiMeiYan Probiotics
- Placebo product
-
Shanghai, Shanghai, China
- +1 more
Jun 2, 2023
Irritable Bowel Syndrome of Diarrhea Type (IBS-D) Trial (OPS-2071, )
Not yet recruiting
- Irritable Bowel Syndrome of Diarrhea Type (IBS-D)
- OPS-2071
- placebo
- (no location specified)
Jun 20, 2023
Irritable Bowel Syndrome With Diarrhea, Irritable Bowel Syndrome Trial (Probiotic, Placebo)
Not yet recruiting
- Irritable Bowel Syndrome With Diarrhea
- Irritable Bowel Syndrome
- Probiotic
- Placebo
- (no location specified)
Feb 22, 2023
Irritable Bowel Syndrome With Diarrhea Trial in Messina (Verum 408, Placebo 407)
Recruiting
- Irritable Bowel Syndrome With Diarrhea
- Verum 408
- Placebo 407
-
Messina, ItalyGioacchino Calapai
Nov 7, 2023
IBS - Irritable Bowel Syndrome Trial in Izmir (Probiotic formulation, Placebo)
Recruiting
- IBS - Irritable Bowel Syndrome
- Probiotic formulation
- Placebo
-
İzmir, TurkeyEge University Faculty of Medicine, Gastroenterology Department
Aug 18, 2022
Irritable Bowel Syndrome, Diarrhea Trial in Rochester (Donor Fecal Microbiota Transplantation, Autologous Fecal Microbiota
Not yet recruiting
- Irritable Bowel Syndrome
- Diarrhea
- Donor Fecal Microbiota Transplantation
- Autologous Fecal Microbiota Transplantation
-
Rochester, MinnesotaMayo Clinic in Minnesota
Mar 17, 2023
Irritable Bowel Syndrome With Diarrhea Trial in Mexico City (lactobacillus LB, )
Recruiting
- Irritable Bowel Syndrome With Diarrhea
- lactobacillus LB
- placebo
-
Mexico City, Choose Any State/Province, MexicoHospital General de Mexico
Mar 15, 2022
Vitamin D on Gut Microbiota, Intestinal Barrier in IBS-D
Recruiting
- Diarrhea-predominant Irritable Bowel Syndrome
-
Xi'an, Shaanxi, ChinaThe second affiliated hospital of xi'an jiaotong university
Oct 21, 2022
Non-erosive Reflux Disease, Diarrhea-Predominant Irritable Bowel Syndrome Trial in Beijing (WPQW granule, WPQW granule simulant)
Recruiting
- Non-erosive Reflux Disease
- Diarrhea-Predominant Irritable Bowel Syndrome
- WPQW granule
- WPQW granule simulant
-
Beijing, Beijing, ChinaXiyuan Hospital of China Academy of Chinese Medical Sciences
May 10, 2022
Colorectal Cancer, Clostridioides Difficile Infection, Diarrhea Trial in Koscierzyna (Sanprobi IBS®)
Recruiting
- Colorectal Cancer
- +2 more
- Sanprobi IBS®
-
Kościerzyna, PolandUnit of Surgery with Unit of Oncological Surgery in Koscierzyna
Aug 24, 2023
Irritable Bowel Syndrome, Irritable Bowel Syndrome With Diarrhea, Irritable Bowel Syndrome With Constipation Trial in Istanbul
Recruiting
- Irritable Bowel Syndrome
- +3 more
- Personalized dietary intervention based on microbiome analysis
- Low-FODMAP diet
-
Istanbul, TurkeyMedipol University Bahcelievler Hospital
Dec 2, 2022
Irritable Bowel Syndrome With Diarrhea Trial in Yongin-si (GTB1, Placebo)
Completed
- Irritable Bowel Syndrome With Diarrhea
- GTB1
- Placebo
-
Yongin-si, Gyeonggi-do, Korea, Republic ofAmorepacific
May 11, 2022
Irritable Bowel Syndrome With Diarrhea Trial in Athens (Med-LFD, Nutritional Guidelines of the British National Institute for
Recruiting
- Irritable Bowel Syndrome With Diarrhea
- Med-LFD
- Nutritional Guidelines of the British National Institute for Health and Care Excellence (NICE) Managing IBS
-
Athens, GreeceAttikon University General Hospital
Oct 14, 2021
Irritable Bowel Syndrome, Irritable Bowel Syndrome With Diarrhea Trial in Ann Arbor (Rifaximin, Glucose and lactulose hydrogen
Recruiting
- Irritable Bowel Syndrome
- Irritable Bowel Syndrome With Diarrhea
- Rifaximin
- Glucose and lactulose hydrogen breath testing
-
Ann Arbor, MichiganUniversity of Michigan
Dec 1, 2021
Irritable Bowel Syndrome With Diarrhea Trial in India (ES 1, HT ES1, Placebo)
Recruiting
- Irritable Bowel Syndrome With Diarrhea
- ES 1
- +2 more
-
Ahmedabad, Gujarat, India
- +7 more
Jun 3, 2022
IBS - Irritable Bowel Syndrome Trial in Roma (Multistrain probiotic)
Completed
- IBS - Irritable Bowel Syndrome
- Multistrain probiotic
-
Roma, RM, ItalyFondazione Policlinico Gemelli
May 21, 2021
Irritable Bowel Syndrome Trial in United States (25mg Eluxadoline, 100mg Eluxadoline)
Recruiting
- Irritable Bowel Syndrome
- 25mg Eluxadoline
- 100mg Eluxadoline
-
Corona, California
- +7 more
Nov 11, 2021
Irritable Bowel Syndrome Trial (Qizhi weitong granules(High), Qizhi weitong granules(Low), Placebo)
Not yet recruiting
- Irritable Bowel Syndrome
- Qizhi weitong granules(High)
- +2 more
- (no location specified)
Oct 29, 2021
Irritable Bowel Syndrome With Diarrhea Trial in Rochester (Eluxadoline)
Completed
- Irritable Bowel Syndrome With Diarrhea
-
Rochester, MinnesotaMayo Clinic
Apr 28, 2021
Irritable Bowel Syndrome With Diarrhea Trial in Los Angeles (Rifaximin, N-acetylcysteine, Placebo)
Active, not recruiting
- Irritable Bowel Syndrome With Diarrhea
- Rifaximin
- +2 more
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Nov 3, 2021
Irritable Bowel Syndrome, Irritable Bowel Syndrome - Constipation, Irritable Bowel Syndrome - Diarrhoea Trial in Leuven, Ede
Recruiting
- Irritable Bowel Syndrome
- +3 more
- Galacto-oligosaccharides (GOS)
- Maltodextrine
-
Leuven, Belgium
- +1 more
Dec 21, 2021